NCT00214500View on ClinicalTrials.gov

A Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 2, 2006

Primary Completion Date

January 29, 2008

Study Completion Date

January 29, 2008

Conditions
Fabry Disease
Interventions
DRUG

migalastat HCl

Trial Locations (5)

10016

New York

20892

Bethesda

30033

Decatur

77030

Houston

90048

Los Angeles

Sponsors
All Listed Sponsors
lead

Amicus Therapeutics

INDUSTRY